Distinct global inflammatory patterns were identified on the MRI scans: polymyalgia rheumatica (extracapsular; 12%), peripheral inflammatory arthritis (37%), spondyloarthropathy (n = 1), and a non ...

Home NICE Guidance Conditions and diseases Musculoskeletal conditions Hip conditions Secukinumab for treating relapsed polymyalgia rheumatica [ID6599] Awaiting development [GID-TA11806] Expected ...

Recognition of polymyalgia rheumatica is straightforward and it is easily treatable.

Vasculitis refers to a group of autoimmune diseases that cause inflammation of the blood vessels. This inflammation can result in tissue damage and, in severe cases, lead to organ failure. The ...

Objective Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease in older people. Contemporary estimates of the incidence and prevalence are lacking, and no previous study has ...

The purpose of this extension study is to assess the safety and tolerability of secukinumab when administered long-term in patients with polymyalgia rheumatica. The study will consist of an up to ...

Find rheumatology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.

Thanks to a community of caring and generous people like you, the Arthritis Foundation is here to help you live better with arthritis. You’re not alone — our community knows the struggles of living ...

3. Farragher TM, Lunt M, Plant D, Bunn DK, Barton A, Symmons DPM. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those ...